clodronic acid has been researched along with Spinal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ala-Kaila, K; Aranko, SM; Blåfield, H; Koivunoro, K; Kormano, M; Laitinen, K; Mäkinen, L; Patronen, A; Perttilä, J; Puolijoki, H; Pylkkänen, L; Rekiaro, M; Sairanen, S; Salmi, J; Seppänen, J; Väisänen, K; Välimäki, MJ; Vesterinen, K | 1 |
| Beyeler, C; Dahinden, C; Gerber, NJ; Hunziker, T; Lämmle, B; Lehmann, T; Olah, AJ; Vock, P | 1 |
1 trial(s) available for clodronic acid and Spinal Diseases
| Article | Year |
|---|---|
Prevention of bone loss by clodronate in early postmenopausal women with vertebral osteopenia: a dose-finding study.
Topics: Absorptiometry, Photon; Bone Density; Bone Diseases, Metabolic; Clodronic Acid; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hip Joint; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Spinal Diseases | 2002 |
1 other study(ies) available for clodronic acid and Spinal Diseases
| Article | Year |
|---|---|
Severe osteoporosis due to systemic mast cell disease: successful treatment with interferon alpha-2B.
Topics: Adult; Clodronic Acid; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; Male; Mastocytosis; Osteoporosis; Palliative Care; Recombinant Proteins; Spinal Diseases; Urticaria Pigmentosa | 1996 |